Fig. 4From: Erythropoietin (EPO)-receptor signaling induces cell death of primary myeloma cells in vitroPrognostic relevance of EPOR expression from four independent patient cohorts. With the use of ROC optimal cutoff derived from each trial, overall survival analysis was performed on EPOR expression in the a TT2, b TT3A, c APEX trial 039 and d APEX trial 040 datasets. Low expression levels of EPOR adversely affect outcomes in all patient cohortsBack to article page